The global medical plastics market was valued at approximately USD 52.9 billion in 2023 and is projected to experience a steady growth rate, with a compound annual growth rate (CAGR) of 7.4% expected between 2024 and 2030. The significant growth in this sector can be attributed to the advancements in the development of plastics and plastic composites used in medical applications, particularly in the production of essential components such as catheters, handles for surgical instruments, and syringes. A rising demand for sophisticated medical devices, especially for in-house use, is expected to drive the need for medical device packaging. Materials like polyethylene, polypropylene, and polycarbonate are becoming increasingly important in the manufacturing of medical devices. Additionally, the expansion of home healthcare owing to its cost-effectiveness compared to hospital-based or intensive care has fueled a greater need for various medical devices.

Demographic trends in the U.S. further support this market growth. According to the latest U.S. census, 16.8% of the U.S. population is aged 65 years and older, with the elderly population expected to reach 74 million by 2030. Notably, individuals over the age of 85 typically require the most intensive care, and this age group is expanding rapidly. In response to this growing need for elderly care, in March 2021, U.S. President Joe Biden proposed a significant investment of USD 400 billion over an eight-year period into Medicaid to support at-home care services for elderly and disabled individuals. This plan also aimed to increase the wages of caregivers. The rising costs and shrinking profit margins have put considerable pressure on healthcare providers and health insurance plans in the U.S., leading the government to implement crucial changes in healthcare funding and insurance coverage, including reforms introduced through the Affordable Care Act (ACA) and Medicaid.

Gather more insights about the market drivers, restrains and growth of the Medical Plastics Market

Product Segmentation Insights:

The Polyphenylsulfone (PPSU) resin segment led the medical plastics market in 2023, accounting for over 51% of the total revenue. This dominance is largely due to the material's excellent heat and chemical resistance, which makes it particularly suited for producing durable surgical tools and medical devices. PPSU's high strength and resilience make it a preferred material in the production of surgical robots and components used in biopharmaceutical processing. Additionally, its high flexural strength and impact resistance are beneficial for producing both single-use and multi-use surgical instruments, especially those that require repeated sterilization via steam.

Polyethylene (PE) is another important material in the medical plastics sector, valued for its resistance to bacteria and cleaning chemicals, making it ideal for use in medical equipment, devices, and other healthcare supplies. Its key characteristics such as impact resistance, chemical stability, flexibility, and minimal moisture absorption make PE suitable for use in medical-grade devices. Moreover, because it is a porous synthetic polymer that does not degrade within the human body, PE is used in various medical applications, including plastic surgery implants, tubing, and bottles.

Polypropylene (PP) is extensively used in the production of medical equipment and protective packaging, thanks to its toughness and durability. The strong chemical bonds of PP make it suitable for producing medical components like disposable syringes, connectors, finger-joint prostheses, non-absorbable sutures, reusable plastic containers, and laboratory items such as beakers and test tubes. Furthermore, PP is particularly beneficial in specialized medical procedures, such as hernia repairs and pelvic organ prolapse surgeries, where it is used in transvaginal mesh implants.

Order a free sample PDF of the Medical Plastics Market Intelligence Study, published by Grand View Research.